Bridgebio Pharma Stock Performance

BridgeBio Pharma Relative Risk vs. Return Landscape

If you would invest  7,364  in BridgeBio Pharma on December 5, 2025 and sell it today you would lose (710.00) from holding BridgeBio Pharma or give up 9.64% of portfolio value over 90 days. BridgeBio Pharma is currently does not generate positive expected returns and assumes 3.088% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of stocks are less volatile than BridgeBio, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days BridgeBio Pharma is expected to under-perform the market. In addition to that, the company is 4.03 times more volatile than its market benchmark. It trades about -0.04 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.04 per unit of volatility.

BridgeBio Pharma Target Price Odds to finish over Current Price

Given the investment horizon of 90 days the stock has the beta coefficient of 1.04 suggesting BridgeBio Pharma market returns are highly reactive to returns on the market. As the market goes up or down, BridgeBio Pharma is expected to follow. Additionally BridgeBio Pharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for BridgeBio Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BridgeBio Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 64.09 67.16 70.23 Details

Intrinsic Valuation Low Real High 59.89 76.31 79.38 Details

Naive Forecast Low Next High 61.66 64.73 67.80 Details

19 Analysts Consensus Low Target High 91.04 100.05 111.05 Details

BridgeBio Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. BridgeBio Pharma is not an exception. The market had few large corrections towards the BridgeBio Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BridgeBio Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BridgeBio Pharma within the framework of very fundamental risk indicators.

BridgeBio Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BridgeBio Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BridgeBio Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

BridgeBio Pharma Price Density Drivers

BridgeBio Pharma Fundamentals Growth

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BridgeBio Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in BridgeBio Stock, please use our How to Invest in BridgeBio Pharma guide.You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.

BridgeBio Pharma's market price often diverges from its book value, the accounting figure shown on BridgeBio's balance sheet. Smart investors calculate BridgeBio Pharma's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since BridgeBio Pharma's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.

It's important to distinguish between BridgeBio Pharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BridgeBio Pharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, BridgeBio Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.